161 related articles for article (PubMed ID: 17704297)
1. The association of ICAM-1 Exon 6 (E469K) but not of ICAM-1 Exon 4 (G241R) and PECAM-1 Exon 3 (L125V) polymorphisms with the development of differentiation syndrome in acute promyelocytic leukemia.
Dore AI; Santana-Lemos BA; Coser VM; Santos FL; Dalmazzo LF; Lima AS; Jacomo RH; Elias J; Falcão RP; Pereira WV; Rego EM
J Leukoc Biol; 2007 Nov; 82(5):1340-3. PubMed ID: 17704297
[TBL] [Abstract][Full Text] [Related]
2. Adhesion molecules and Differentiation Syndrome: phenotypic and functional analysis of the effect of ATRA, As2O3, phenylbutyrate, and G-CSF in acute promyelocytic leukemia.
Cunha De Santis G; Tamarozzi MB; Sousa RB; Moreno SE; Secco D; Garcia AB; Lima AS; Faccioli LH; Falcão RP; Cunha FQ; Rego EM
Haematologica; 2007 Dec; 92(12):1615-22. PubMed ID: 18055984
[TBL] [Abstract][Full Text] [Related]
3. The impact of ICAM-1, CCL2 and TGM2 gene polymorphisms on differentiation syndrome in acute promyelocytic leukemia.
Mohammadzadeh Z; Omidkhoda A; Chahardouli B; Hoseinzadeh G; Moghaddam KA; Mousavi SA; Rostami S
BMC Cancer; 2021 Jan; 21(1):46. PubMed ID: 33422029
[TBL] [Abstract][Full Text] [Related]
4. [The retinoic acid syndrome, a complication of acute promyelocytic leukemia therapy].
Martín Del Pozo M; Cisneros De La Fuente E; Solano F; Martín ML; De La Serna J
An Med Interna; 2001 Apr; 18(4):195-200. PubMed ID: 11496539
[TBL] [Abstract][Full Text] [Related]
5. Retinoic acid syndrome.
Datta D; Gerardi DA
Conn Med; 2003 Oct; 67(9):541-3. PubMed ID: 14619342
[TBL] [Abstract][Full Text] [Related]
6. [Acute renal failure in the transretinoic syndrome].
Sastre A; Gago E; Baños M; Gómez E
Nefrologia; 2007; 27(2):184-90. PubMed ID: 17564563
[TBL] [Abstract][Full Text] [Related]
7. [Paralytic ileus during treatment of acute promyelocytic leukemia with all-trans retinoic acid].
Kanisawa Y; Kawanishi N; Hisai H; Araya H; Akiyama T; Takahari D
Rinsho Ketsueki; 2000 Aug; 41(8):687-9. PubMed ID: 11020999
[TBL] [Abstract][Full Text] [Related]
8. Predictive factors for all-trans retinoic acid-related differentiation syndrome in patients with acute promyelocytic leukemia.
Leblebjian H; DeAngelo DJ; Skirvin JA; Stone RM; Wadleigh M; Werner L; Neuberg DS; Bartel S; McDonnell AM
Leuk Res; 2013 Jul; 37(7):747-51. PubMed ID: 23643326
[TBL] [Abstract][Full Text] [Related]
9. [All-trans retinoic acid syndrome. Case report and a review of the literature].
Carrillo-Esper R; Carvajal-Ramos R; Contreras-Domínguez V; Hernández-Aguilar C; Romano-Estrada L; Melo-Martínez C
Gac Med Mex; 2004; 140(5):547-52. PubMed ID: 15559237
[TBL] [Abstract][Full Text] [Related]
10. Acute renal failure during ATRA treatment.
Yarali N; Tavil B; Kara A; Ozkasap S; Tunç B
Pediatr Hematol Oncol; 2008 Mar; 25(2):115-8. PubMed ID: 18363177
[TBL] [Abstract][Full Text] [Related]
11. Sweet's syndrome followed by retinoic acid syndrome during the treatment of acute promyelocytic leukemia with all-trans retinoic acid.
Takada S; Matumoto K; Sakura T; Shiozaki H; Miyawaki S
Int J Hematol; 1999 Jul; 70(1):26-9. PubMed ID: 10446491
[TBL] [Abstract][Full Text] [Related]
12. Acute promyelocytic leukemia: recent advances in diagnosis and management.
Lo-Coco F; Ammatuna E; Montesinos P; Sanz MA
Semin Oncol; 2008 Aug; 35(4):401-9. PubMed ID: 18692690
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-8 is not a predictive biomarker for the development of the acute promyelocytic leukemia differentiation syndrome.
Yamamoto de Almeida L; Pereira-Martins DA; Lima ASG; Baggio MS; de Araujo Koury LC; Lange AP; Bassi SC; Scheucher PS; Rego EM
BMC Cancer; 2020 Aug; 20(1):821. PubMed ID: 32859169
[TBL] [Abstract][Full Text] [Related]
14. Celastrol inhibits lung infiltration in differential syndrome animal models by reducing TNF-α and ICAM-1 levels while preserving differentiation in ATRA-induced acute promyelocytic leukemia cells.
Xu LM; Zheng YJ; Wang Y; Yang Y; Cao FF; Peng B; Xu XF; An HZ; Zheng AX; Zhang DH; Uzan G; Yu YZ
PLoS One; 2014; 9(8):e105131. PubMed ID: 25116125
[TBL] [Abstract][Full Text] [Related]
15. All-trans-retinoic acid-induced myositis in a child with acute promyelocytic leukemia.
Citak FE; Ezer U; Akkaya E; Ozbulbul N; Bahce M; Kurekci AE
Haematologica; 2006 Aug; 91(8 Suppl):ECR35. PubMed ID: 16923519
[TBL] [Abstract][Full Text] [Related]
16. Adhesion molecule polymorphisms in acute renal allograft rejection.
Khazen D; Jendoubi-Ayed S; Gorgi Y; Sfar I; Abderrahim E; Ben Abdallah T; Ayed K
Transplant Proc; 2007 Oct; 39(8):2563-4. PubMed ID: 17954174
[TBL] [Abstract][Full Text] [Related]
17. Sweet's syndrome associated with retinoic acid syndrome in a patient with promyelocytic leukemia.
Astudillo L; Loche F; Reynish W; Rigal-Huguet F; Lamant L; Pris J
Ann Hematol; 2002 Feb; 81(2):111-4. PubMed ID: 11907794
[TBL] [Abstract][Full Text] [Related]
18. All-trans-retinoic acid and arsenic trioxide as initial therapy for acute promyelocytic leukemia.
Quezada G; Kopp L; Estey E; Wells RJ
Pediatr Blood Cancer; 2008 Jul; 51(1):133-5. PubMed ID: 18293388
[TBL] [Abstract][Full Text] [Related]
19. All- trans-retinoic acid-induced erythema nodosum in patients with acute promyelocytic leukemia.
Kuo MC; Dunn P; Wu JH; Shih LY
Ann Hematol; 2004 Jun; 83(6):376-80. PubMed ID: 14648024
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility to active decompensated cirrhosis is associated with polymorphisms of intercellular adhesion molecule-1 (ICAM-1) in chronic HBV carriers.
Zhang XQ; Hong XJ; Bai XJ
J Viral Hepat; 2008 Mar; 15(3):173-8. PubMed ID: 18233990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
